A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule transthyretin stabilizer, for the treatment of transthyretin ...

Our cardiac specialists at Bayview Medical Center in Baltimore, Maryland, provide comprehensive care and treatment for patients diagnosed with heart and vascular conditions.